ANM Mo99 facility operating licence application - invitation to make submissions on ANSTO's application for a facility licence.
The CEO of ARPANSA intends making a decision under section 32 of the Australian Radiation Protection and Nuclear Safety Act 1998 on the following licence application:
Application by the Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine Pty Ltd for a licence to operate a nuclear installation being a facility for the production of molybdenum-99 at the Lucas Heights Science and Technology Centre, New Illawarra Road, Lucas Heights, New South Wales.
In accordance with Regulation 40 of the Australian Radiation Protection and Nuclear Safety Regulations 1999, the CEO of ARPANSA invites submissions from the public about the application. The CEO will take submissions received into account when making a decision on whether or not to grant the licence for the application.
The application and supporting documentation can be downloaded below.
Submissions must be received by 5 June 2017.
Application Number A0309: ANSTO Nuclear Medicine Molybdenum-99 Facility (ANM Mo99)
Effective control plan
Safety management plan
Radiation protection plan
Waste management plan
Structures, systems, components and equipment
Safety analysis report
Operating limits and conditions
Commissioning plan process
Commissioning plan systems
Safe and secure operations
These documents are provided in PDF format only. If you are unable to access PDFs, please contact us for access to an alternative version of the information.
ARPANSA's CEO, Dr Carl-Magnus Larsson issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) on 12 April 2018 to operate the ANSTO Nuclear Medicine Molybdenum-99 Facility.
The statement of reasons, regulatory assessment report and submission received from the Medical Practitioners Against War can be found on our announcement page.
© Commonwealth of Australia